Published in J Antimicrob Chemother on December 01, 2002
High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother (2004) 2.41
DNA microarray for detection of macrolide resistance genes. Antimicrob Agents Chemother (2006) 1.09
Properties of novel international drug-resistant pneumococcal clones identified in day-care centers of Lisbon, Portugal. J Clin Microbiol (2005) 0.97
Patient knowledge and perception of upper respiratory infections, antibiotic indications and resistance. Patient Prefer Adherence (2008) 0.81
A population-based analysis of pneumococcal disease mortality in California, 1989-1998. Public Health Rep (2005) 0.81
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. Antimicrob Agents Chemother (2007) 0.80
Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study. Int J Gen Med (2011) 0.75
Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections. MedGenMed (2005) 0.75
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil. Trop Geogr Med (1971) 11.37
More extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1991) 11.28
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother (1990) 6.11
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother (1990) 5.81
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother (1997) 4.20
Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis (1971) 3.76
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol (1994) 3.61
Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother (1996) 3.44
Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet (1975) 3.34
Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother (1985) 3.34
Vacuum blood-culture bottles inhibiting growth of Candida and fostering growth of Bacteroides. Lancet (1974) 3.26
Comparison of polyacrylamide and agarose gel thin-layer isoelectric focusing for the characterization of beta-lactamases. Antimicrob Agents Chemother (1983) 3.19
Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol (1985) 3.14
Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes. Mol Gen Genet (1987) 3.12
Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect (2011) 2.99
Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States. N Engl J Med (1982) 2.97
Beta-lactamases. Br Med Bull (1984) 2.90
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect (2010) 2.63
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet (1981) 2.41
The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med (1978) 2.29
Spread of a "Pseudomonas-specific" beta-lactamase to plasmids of enterobacteria. J Bacteriol (1982) 2.28
Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis (1997) 2.23
An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother (1986) 2.21
SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother (2000) 2.15
Impact of colloidal bismuth subnitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. Am J Gastroenterol (1995) 2.14
Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother (1992) 2.07
Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect (2006) 1.87
Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother (1980) 1.79
Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis (1994) 1.78
Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg). Int J Oral Maxillofac Surg (2007) 1.76
30 years of penicillin-resistant S pneumoniae: myth or reality? Lancet (1997) 1.70
Broad-spectrum, transmissible beta-lactamases. N Engl J Med (1988) 1.70
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrob Agents Chemother (1994) 1.70
Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease. Antimicrob Agents Chemother (1983) 1.65
Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin. Eur Respir J (1995) 1.61
Computer-generated plots of results of antimicrobial-susceptibility tests. JAMA (1969) 1.58
Catheter sepsis: the clue is the hub. Surgery (1985) 1.58
Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol (1995) 1.55
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J Antimicrob Chemother (2001) 1.53
Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis? Clin Infect Dis (1995) 1.51
Recent experience with bacillemia due to gram-negative organisms. J Infect Dis (1971) 1.50
Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother (1985) 1.45
Controlled trial of endoscopic sclerosis in bleeding peptic ulcers. Lancet (1987) 1.44
Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis (1993) 1.44
Diagnosis of gonorrhea in male patients by culture of uncentrifuged first-voided urine. JAMA (1977) 1.42
Chloramphenicol-resistant pneumococci. Lancet (1981) 1.42
[Infection of the gastrointestinal tract by cytomegalovirus]. Gastroenterol Hepatol (1997) 1.40
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. Antimicrob Agents Chemother (1993) 1.39
Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrob Agents Chemother (1996) 1.39
Novel plasmid-mediated beta-lactamase in members of the family Enterobacteriaceae from Ohio. Antimicrob Agents Chemother (1986) 1.38
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37
Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay. Antimicrob Agents Chemother (1990) 1.36
International comparison of prevalence of resistance to antibiotics. JAMA (1978) 1.34
Catheter sepsis due to Staphylococcus epidermidis during parenteral nutrition. Surg Gynecol Obstet (1980) 1.34
Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr (1985) 1.32
Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis (1996) 1.26
Single-disk diffusion testing (Kirby-Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. J Clin Microbiol (1980) 1.24
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20
Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J (2007) 1.20
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J (2009) 1.20
Bloodstream infections in adults: importance of healthcare-associated infections. J Infect (2007) 1.19
IS6770, an enterococcal insertion-like sequence useful for determining the clonal relationship of clinical enterococcal isolates. J Infect Dis (1994) 1.17
Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1990) 1.17
Molecular epidemiology of OHIO-1 beta-lactamase. Antimicrob Agents Chemother (1987) 1.14
A colorimetric procedure for measuring beta-lactamase activity. Anal Biochem (1988) 1.11
Guidelines for the management of adult lower respiratory tract infections--summary. Clin Microbiol Infect (2011) 1.11
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats. Antimicrob Agents Chemother (1977) 1.11
Bacterial infection in renal homotransplant recipients. A study of fifty-three bacteremic episodes. Am J Med (1972) 1.11
Role of beta-lactamase in expression of resistance by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1987) 1.11
Listeroisis in immunosuppressed patients. A cluster of eight cases. Am J Med (1975) 1.08
A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis (1990) 1.08
Thoracic infection caused by Streptococcus milleri. Eur Respir J (1998) 1.05
Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America. Ann Intern Med (1993) 1.04
R factor-mediated increments in levels of resistance to and enzymatic degradation of penicillins and cephalosporins. Antimicrob Agents Chemother (Bethesda) (1967) 1.02
Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen. J Hosp Infect (1996) 1.02
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. J Antimicrob Chemother (1985) 1.01
Bacteria in total parenteral nutrition catheters: where do they come from? Lancet (1983) 1.01
Association of cephalosporinase activity, cephalothin resistance, and episome-mediated drug resistance in Klebsiella strains. Antimicrob Agents Chemother (Bethesda) (1966) 0.99
Multiple antibiotic resistance plasmids in Enterobacteriaceae isolated from diarrhoeal specimens of hospitalized children in Indonesia. J Antimicrob Chemother (1985) 0.99
Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1974) 0.98
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention. Eur J Clin Microbiol Infect Dis (2008) 0.98
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study. Clin Microbiol Infect (2009) 0.97
Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia. Antimicrob Agents Chemother (Bethesda) (1968) 0.97
[Salmonella typhi osteomyelitis]. Med Clin (Barc) (1983) 0.96
Carbapenems in clinical practice: a guide to their use in serious infection. Int J Antimicrob Agents (1999) 0.96
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. J Antimicrob Chemother (1984) 0.96
Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae. N Engl J Med (1995) 0.95
Failure of therapy in pseudomonas endocarditis: selection of resistant mutants. J Infect Dis (1986) 0.95
Relapsing infection due to Enterobacter species: lessons of heterogeneity. Clin Infect Dis (1997) 0.93
Laboratory surveillance of synergy between and resistance to trimethoprim and sulfonamides. Rev Infect Dis (1982) 0.91
Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis Suppl (1994) 0.91
Cytomegalovirus mononucleosis-associated antral gastritis simulating malignancy. Arch Intern Med (1987) 0.90
International surveillance of prevalence of antibiotic resistance. J Antimicrob Chemother (1977) 0.90
The second of two epidemics of histoplasmosis resulting from work on the same starling roost. Am Rev Respir Dis (1966) 0.90
Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak. N Engl J Med (1966) 0.90
The epidemiology of domestic injurious falls in a community dwelling elderly population: an outgrowing economic burden. Eur J Public Health (2009) 0.89
Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. J Infect Dis (1993) 0.89
Mechanisms of resistance to cephalosporins in ampicillin-resistant Escherichia coli. J Infect Dis (1973) 0.88
Spontaneous spleen rupture during typhoid fever. Int J Infect Dis (2000) 0.88